FOA Title: 
Low Cost Detection of Cognitive Decline in Clinical Settings (R01 Clinical Trial Required)
Grant Type: 
RFA-AG-20-051
Primary IC: 
NIA
Release Date: 
Sep 27 2019
Expiration Date: 
Jan 31 2020
AC Source: 
R01
Purpose: 
This Funding Opportunity Announcement (FOA) invites applications to pursue validation studies of cognitive screening instruments or assessments in clinical settings and to translate these screening and assessment tools into electronic health record (EHR) systems that can assist physicians in making clinically meaningful care recommendations for patients experiencing cognitive decline. This FOA requires prior preliminary data gathered during the development of cognitive screening tools and/or assessments. This FOA will also support research to validate these tools as well as their implementation in large clinical settings. Plans for validation of cognitive impairment against relevant Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) biomarkers are encouraged but not required.